Z. Khalkhali-ellis et al., Estrogen and progesterone regulation of human fibroblast-like synoviocyte function in vitro: Implications in rheumatoid arthritis, J RHEUMATOL, 27(7), 2000, pp. 1622-1631
Objective. Despite increasing evidence regarding the significance of sex ho
rmones in rheumatoid arthritis (RA), their etiopathological role and potent
ial longterm effect on joint destruction remain unclear. We hypothesized th
at estrogen receptors (ER-alpha) are present in fibroblast-like synsviocyte
s, and 17 beta-estradiol can modulate the production and activity of matrix
degrading enzymes produced by these cells. Thus, depending on the endocrin
e balance, fibroblast-like synoviocyte activity call be suppressed or enhan
ced, leading to amelioration or exacerbation of the disease process, respec
tively.
Methods, By utilizing an in vitro cartilage invasion model, in combination
with the molecular analyses of hormone receptors, matrix metalloproteinases
(MMP) and their respective inhibitors, we investigated the effect of hormo
nes (i.e., estrogen and progesterone) on fibroblast-like synoviocyte phenot
ypic changes, with particular emphasis on their functional interactions wit
h cartilage.
Results. Our studies reveal the presence of functional ER-alpha in fibrobla
st-like synoviocytes. The findings indicate that estrogen exerts a stimulat
ory effect, while progesterone has an inhibitory effect on the expression o
f MMP, their tissue inhibitors (TIMP), and enzymatic activity of MMP produc
ed by these cells. Furthermore, transfection of fibroblast-like synoviocyte
s with the ER-alpha gene resulted in the increased degradation and invasion
of cartilage.
Conclusion. We identified the presence of functional ER-alpha in fibroblast
-like synoviocytes. This renders fibroblast-like synoviocytes as target cel
ls for hormonal regulation. The regulatory effect of estrogen is partly tar
geted to the MMP and their respective inhibitors associated with fibroblast
-like synoviocytes. Such studies provide a link between hormonal status and
disease activity in RA and open new venues for future therapeutic interven
tion to combat this debilitating disease.